首页> 外文期刊>Life sciences >Chloride channel blocker IAA-94 increases myocardial infarction by reducing calcium retention capacity of the cardiac mitochondria
【24h】

Chloride channel blocker IAA-94 increases myocardial infarction by reducing calcium retention capacity of the cardiac mitochondria

机译:氯化物通道阻滞剂IAA-94通过减少心肌细胞粒细胞的钙保留容量来增加心肌梗塞

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Indanyloxyacetic acid-94 (IAA-94), an intracellular chloride channel blocker, is shown to ablate cardioprotection rendered by ischemic preconditioning (IPC), N (6)-2-(4-aminophenyl) ethyladenosine or the PKC activator phorbol 12-myristate 13-acetate and cyclosporin A (CsA) in both ex-vivo and in-vivo ischemia-reperfusion (IR) injury. Thus signifying the role of the IAA-94 sensitive chloride channels in mediating cardio-protection upon IR injury. Although IAA-94 sensitive chloride currents are recorded in cardiac mitoplast, there is still a lack of understanding of the mechanism by which IAA-94 increases myocardial infarction (MI) by IR injury. Mitochondria are the key arbitrators of cell life and death pathways. Both oxidative stress and calcium overload in the mitochondria, elicit pathways resulting in the opening of mitochondrial permeability transition pore (mPTP) leading to cell death. Therefore, in this study we explored the role of IAA-94 in MI and in maintaining calcium retention capacity (CRC) of cardiac mitochondria after IR. IAA-94 inhibited the CRC of the isolated cardiac mitochondria in a concentration-dependent manner as measured spectrofluorimetrically using calcium green-5 N. Interestingly, IAA-94 did not change the mitochondrial membrane potential. Further, CsA a blocker of mPTP opening could not override the effect of IAA-94. We also showed for the first time that IAA-94 perfusion after ischemic event augments MI by reducing the CRC of mitochondria. To conclude, our results demonstrate that the mechanism of IAA-94 mediated cardio-deleterious effects is via modulating the mitochondria CRC, thereby playing a role in mPTP opening. These findings highlight new pharmacological targets, which can mediate cardioprotection from IR injury.
机译:茚满氧基乙酸-94(IAA-94),一种细胞内氯化物通道阻断剂被示出为缺血预处理(IPC),N(6)-2-(4-氨基苯基)乙基腺苷或PKC活化剂Phorbol 12-Myristate所渗透的心脏保护剂在前体内和体内缺血再灌注(IR)损伤中,13-乙酸盐和环孢菌素A(CSA)。因此,在IAA-94敏感的氯化物通道中致力于在IR介导的心脏保护中的作用。虽然IAA-94敏感的氯化物电流记录在心脏模骨中,但仍然缺乏了解IAA-94通过IR损伤增加心肌梗死(MI)的机制。线粒体是细胞生命和死亡途径的关键仲裁员。线粒体氧化应激和钙过载,引发途径,导致线粒体渗透过渡孔(MPTP)的开放,导致细胞死亡。因此,在这项研究中,我们探讨了IAA-94在MI中的作用以及IR后维持心肌细胞粒细胞的钙保留容量(CRC)。 IAA-94以浓度依赖性方式抑制分离的心脏线粒体的CRC,如使用钙绿-5 N.使用钙绿-5 N.测得的光谱荧光素。有趣的是,IAA-94没有改变线粒体膜电位。此外,CSA的MPTP开口阻挡剂不能超越IAA-94的效果。我们还通过减少线粒体的CRC来说,我们首次展示了IAA-94缺血后灌注MI。为了得出结论,我们的结果表明,IAA-94介导的心脏有害效果的机制是通过调节线粒体CRC的作用,从而在MPTP开口中发挥作用。这些发现突出了新的药理学靶标,可以从IR损伤中介导心脏保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号